Court lifts temporary means of protection for products branded with name “MIDOLAT” /”МИДОЛАТ”
On August 20, the district court of Riga has cancelled its prior verdict made on July 26 to impose the temporary means of protection. The cancelled verdict provided for seizing and recalling from distribution all medications of Olainfarm labelled with textual designations “MIDOLAT” and “МИДОЛАТ”, as well as by prohibiting the use of the textual trademark “MIDOLAT”/”МИДОЛАТ” in commercial activities of Olainfarm. This cancellation verdict was made without the right to appeal.
Panic driven actions by „Grindeks” targeted at preventing the competition from producing generic meldonium have failed. Verdict of Riga district court ensures that despite the obstacles put by competition, it is a matter of weeks before Latvian people will have access to top quality Latvian made meldonium of Olainfarm,” says Salvis Lapins, member of „Olainfarm’s” Board.
It is almost a year since “MIDOLAT”/”МИДОЛАТ” was registered as a trade mark of „Olainfarm” in Latvia. Meldonium produced by „Olainfarm” in other countries is known and growing under the trade name “Vazonat®”.
AS „Olainfarm“ is one of the largest companies in Baltic countries with nearly 40 years of experience in production of medicines and chemical and pharmaceutical products. The key principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Currently products of “Olainfarm” are being exported to more than 30 countries worldwide, including the Baltics, Russia, other CIS, Europe, North America, Asia, and Australia
Information prepared by
Member of the Board
tel. +371 6 7013717,
Cell: + 371 2 6448873
Fax. + 371 6 7013777